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Summary
Objectives: Carotid ultrasonography is noninvasive and effective for the assessment
of atherosclerotic lesions. The relationship between carotid ultrasound ﬁndings and
presence and severity of coronary artery disease (CAD) was examined in Japanese
patients.
Methods and results: Subjects were 116 patients who underwent carotid ultrasonog-
raphy and coronary angiography. In carotid ultrasonography, mean-intima-media
thickness (IMT), common carotid artery max IMT, bifurcation max IMT, plaque num-
ber, and plaque score (PS). The coronary angiographic data was obtained in the same
period as carotid ultrasonography was performed. Patients were divided into two
groups based on the presence or absence of coronary artery stenosis (CAS and non-
CAS) and CAS group was further categorized into three groups, 1 vessel disease (1VD),
2VD, and 3VD. Physical ﬁndings, biochemical data, and carotid ultrasonogram data
between the groups were compared. Items showing a signiﬁcant difference between
CAS and non-CAS were age, gender (male), incidence of diabetes and dyslipidemia,
fasting blood sugar (FBS), triglyceride, HDL-cholesterol (HDL-C), high-sensitivity C-
reactive protein, and all carotid ultrasound ﬁndings. All of the above parameters
also showed a signiﬁcant difference between four different severity groups. Step-
wise logistic regression analysis was performed to determine which factors predict
the presence and/or severity of CAS. High PS showed the strongest predictive value
for both and followed by low HDL-C and high FBS. The cut-off value of PS obtained
by receiver operating characteristic curve for predicting the presence of CAS was
1.9.
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Introduction
Atherosclerosis is a fundamental cause of vari-
ous cardiovascular diseases and furthermore causes
fatal coronary artery disease (CAD). Namely, early
detection of CAD and particularly detection while
the patient is asymptomatic is clinically crucial.
Carotid ultrasonography, a noninvasive exami-
nation, is effective in assessing atherosclerotic
lesions. There are numerous reports on the rela-
tionship between carotid ultrasound ﬁndings and
other risk factors like hypertension [1] or diabetes
[2], aortic calciﬁcation [3,4], and CAD [5—7]. Most
of them, however, are studies on predicting the
onset of CAD or on its presence or absence based
on carotid ultrasound ﬁndings. Moreover, very few
reports were reported for the relation between
carotid ultrasound ﬁndings and the severity of CAD
[8]. Thus, if not only the presence of CAD but also its
severity can be predicted with carotid ultrasound
ﬁndings, this will prove of great clinical use in early
detection and treatment of CAD.
Another focus of this work was parameters for
carotid ultrasonography. Many papers have used
intima-media thickness (IMT) as main parame-
ter in carotid ultrasound ﬁndings, but relatively
few reports have used assessments of plaque like
the plaque score (PS) and plaque number (PN)
[5,6,9,10].
In the present study, in addition to IMT, PS and PN
were assessed to examine the relationship between
these carotid ultrasound ﬁndings and the presence
and severity of CAD in Japanese patients.
Methods
Subjects
Subjects were, of patients admitted to Fukuoka
University Chikushi Hospital from April 2004
to December 2005 with CAD or its suspicion
(n = 119), those who underwent carotid ultrasonog-
raphy and coronary angiography simultaneously.
Informed consent was obtained before enroll-
ment in the trial, and the trial was reviewed
and approved by the responsible institutional
review boards. Of these patients, those following
carotid angioplasty and those with aortitis syn-
drome were excluded (n = 1), and patients with
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PS by carotid ultrasonography together with other risk
lly relevant to predict the presence and severity of CAS.
Cardiology. Published by Elsevier Ireland Ltd. All rights
oorly recorded carotid ultrasonograms precluding
easurement were excluded (n = 2), yielding a total
f 116 subjects (average age: 68.5± 10.8 years,
ale:female = 68:48).
The risk factor variables evaluated in the present
tudy included age, sex, hypertension, dyslipi-
emia, diabetes mellitus (DM), and smoking status.
moking was deﬁned based on its active presence in
he last 6 months; an ex-smoker was someone who
uit the habit 6 months before, and a nonsmoker
as someone who did not smoke in the last 15 years.
Hypertension was deﬁned as receiving antihy-
ertensive medication or if the averaged systolic
r diastolic blood pressure measured was above
40mmHg or 90mmHg at least two different occa-
ions, respectively. Dyslipidemia was deﬁned as
otal plasma cholesterol of >220mg/dl or HDL-
holesterol of <40mg/dl or triglyceride levels of
150mg/dl or documented hypercholesterolemia
equiring lipid-lowering drug therapy. Diabetes
ellitus was deﬁned as present if the patient
ad a history of diabetes, diabetic therapeutic
rug administration, or if fasting plasma glucose
xceeded 126mg/dl or 200mg/dl at any time.
Upon admittance, height and weight were mea-
ured and BMI was calculated, and electrocardio-
raphy, chest radiography, and echocardiography
ere performed as routine examinations during
dmittance. Blood pressure levels were measured
rior to carotid ultrasonography at least two times
t a sitting position bilaterally. The averaged value
as used for analysis. In addition, results of blood
aken during early morning fasting were used for
iochemical data.
ssessment of carotid ultrasonography
therosclerotic changes of the bilateral carotid
rteries were assessed by ultrasonography. High
esolution B mode, color Doppler, and pulse Doppler
ltrasonography of both carotid arteries were per-
ormed with an ultrasound scanner (Toshiba Power
ision 8000) equipped with a 7.5MHz linear array
ransducer. Patients were examined in the supine
osition with the head tilted backwards. After the
arotid arteries were located by transverse scans,
he probe was rotated 90◦ to obtain and record
longitudinal image of the anterior and poste-
ior walls. A careful search was performed for all
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nterfaces of up to 12 different sites (right and
eft, near and far walls, distal common, bifurca-
ion, and proximal internal carotid artery). When
n optimal longitudinal image was obtained, it
as stored on videotape. The mean-IMT was the
veraged IMT of both distal common arteries. The
-maximum IMT (Cmax-IMT) was the most hyper-
rophic site measured at the distal common carotid
rtery. B-maximum IMT (Bmax-IMT) was the most
ypertrophic site measured at the bifurcation and
he internal carotid arteries.
Plaque was designated as focal intima-media
hickening greater than or equal to 1.1mm. The PS
as calculated by summing all plaque thicknesses.
he PN was the total number of plaques [11,12].
ll measurements were performed by several sono-
raphers who were unaware of detail the clinical
nformation for each patient.ssessment of coronary angiography
oronary angiography was performed percuta-
eously using either a Judkins or multipurpose
atheter. Coronary angiograms were recorded
S
T
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Table 1 Comparison of clinical parameters between CAS a
CAS (n = 75)
General
Gender (M/F) 49/26
Age (years) 70.4± 9.4
BMI (%) 23.5± 3.7
HT (n (%)) 58 (77.3%)
DM (n (%)) 32 (42.7%)
DL (n (%)) 52 (69.3%)
Smoker (n (%)) 24 (32.4%)
Biochemical data
FBS (mg/dl) 101 (89, 139)
HbA1c (%) 6.6± 1.8
T-chol (mg/dl) 191.4± 38.5
TG (mg/dl) 110 (84, 154)
HDL-C (mg/dl) 48.5± 11.0
WBC (l) 6362± 1981
hs-CRP (mg/dl) 0.2 (0.1, 0.7)
Carotid data
Mean-IMT (mm) 0.90± 0.36
Cmax-IMT (mm) 1.36± 0.79
Bmax-IMT (mm) 2.03± 1.47
PS 5.7 (2.6, 11.9)
PN 3.0 (1.0, 4.0)
Data are means± S.D., median (25th and 75th percentile), or
Kruskal—Wallis test for FBS, TG, CRP, PS, and PN, while the others
artery; non-CAS, no stenosis of coronary artery; BMI, body mass inde
FBS, fasting blood sugar; T-chol, total cholesterol; TG, triglyceride;
cell; hs-CRP, high-sensitivity C-reactive protein; Cmax-IMT, comm
maximum intima-media thickness; PS, plaque score; PN, plaque nu27
nd divided into 15 segments according to the
lassiﬁcation of the American Heart Association
rading Committee. The presence of stenosis was
etermined by several experienced skillful cardiol-
gists based on viewing the angiographic cineﬁlm
btained after the direct intracoronary injection
f isosorbide dinitrate. Arterial stenosis were cat-
gorized into seven different levels (0, 25, 50, 75,
0, 99% stenosis or total occlusion). More than 75%
uminal narrowing, actually 51% or more stenosis,
as considered signiﬁcant coronary artery steno-
is (CAS). Angiographic ﬁndings were analyzed by
bservers who were blinded to the carotid ultra-
ound data. In addition, the group with CAS was
ivided according to the number of diseased vessels
nto a group with single vessel disease (1VD), two
essel disease (2VD), or three vessel disease (3VD).
n other words, all 116 subjects were subclassiﬁed
nto these four different severity groups.tatistical analysis
o examine the relationship between carotid ultra-
ound ﬁndings and CAD, all of the 116 subjects were
nd non-CAS patients
Non-CAS (n = 41) p value
19/22 0.0061
65.1± 12.3 0.0179
23.2± 3.2 0.7133
28 (68.3%) 0.2878
7 (17.1%) 0.0053
19 (46.3%) 0.0151
10 (25.0%) 0.4078
93 (86, 104) 0.0148
5.8± 1.4 0.0642
193.1± 34.2 0.8171
91 (77, 123) 0.0181
56.6± 14.3 0.0012
5760± 1964 0.1231
0.1 (0.0, 0.2) 0.0015
0.77± 0.20 0.0106
1.02± 0.43 0.0124
0.90± 1.12 <0.0001
1.3 (0.0, 3.2) <0.0001
1.0 (0.0, 1.3) <0.0001
n (%). We performed chi-square test for categorical data,
were followed by t-test. CAS, with >75% stenosis of coronary
x; HT, hypertension; DM, diabetes mellitus; DL, dyslipidemia;
HDL-C, high density lipoprotein cholesterol; WBC, white blood
on maximum intima-media thickness; Bmax-IMT, bifurcation
mber.
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Table 2 Comparison of clinical parameters among groups with different severity of CAS
Normal (n = 41) 1VD (n = 31) 2VD (n = 24) 3VD (n = 20) p value
General
Gender (M/F) 19/22 17/14 18/6 14/6 0.0211
Age (years) 65.1± 12.3 70.8± 9.4 67.7± 9.3 73.2± 9.0 0.0219
BMI (%) 23.1± 3.2 23.4± 3.9 23.4± 4.1 23.7± 2.9 0.9621
HT (n (%)) 28 (68.3%) 24 (77.4%) 19 (79.2%) 15 (75%) 0.4487
DM (n (%)) 7 (17.1%) 9 (29.0%) 12 (50.0%) 11 (55.0%) 0.0006
DL (n (%)) 19 (46.3%) 20 (64.5%) 19 (79.2%) 13 (65.0%) 0.0398
Smoker (n (%)) 10 (25.0%) 9 (30.0%) 9 (37.5%) 6 (30.0%) 0.4781
Biochemical data
FBS (mg/dl) 93 (86, 104) 96 (84, 140) 115 (99, 137) 98 (91, 142) 0.0044
HbA1c (%) 5.8± 1.4 6.3± 1.7 6.6± 2.0 6.8± 1.9 0.2726
T-chol (mg/dl) 193.1± 34.2 189.1± 39.8 193.0± 37.7 192.8± 39.4 0.9717
TG (mg/dl) 91 (77, 123) 109 (83, 140) 116 (90, 167) 112 (86, 160) 0.0101
HDL-C (mg/dl) 56.6± 14.3 49.5± 12.0 49.4± 12.5 46.2± 7.2 0.0101
WBC (l) 5760± 1964 5970± 1714 6883± 1898 6325± 2376 0.1567
hs-CRP (mg/dl) 0.1 (0.0, 0.2) 0.2 (0.1, 0.5) 0.4 (0.1, 0.9) 0.1 (0.1, 0.7) 0.0041
Carotid data
Mean-IMT (mm) 0.77± 0.20 0.85± 0.25 0.86± 0.21 1.04± 0.56 0.0182
Cmax-IMT (mm) 1.02± 0.43 1.23± 0.59 1.28± 0.69 1.65± 1.09 0.0110
Bmax-IMT (mm) 0.90± 1.12 1.78± 1.55 1.62± 1.42 2.87± 1.05 <0.0001
PS 1.3 (0.0, 3.2) 3.8 (1.5, 8.4) 4.8 (2.0, 8.4) 7.9 (6.7, 12.0) <0.0001
PN 1.0 (0.0, 1.3) 2.0 (1.0, 3.0) 2.0 (1.0, 3.0) 4.0 (3.0, 5.0) <0.0001
Data are means± S.D., median (25th and 75th percentile), or n (%). We performed Kruskal—Wallis test with rank score for
categorical data, FBS, TG, CRP, PS, and PN considering severity of CAS, while the others were analyzed by one-way ANOVA, and
multiple comparison followed by Tukey—Kramer. BMI, body mass index; HT, hypertension; DM, diabetes mellitus; DL, dyslipidemia;
ide;
omm
e nu
s
w
rFBS, fasting blood sugar; T-chol, total cholesterol; TG, triglycer
cell; ha-CRP, high-sensitivity C-reactive protein; Cmax-IMT, c
maximum intima-media thickness; PS, plaque score; PN, plaqu
divided into two groups, a group with signiﬁcant
CAS group and a group without such lesions (non-
CAS group). Using a t-test and 2 test, the carotid
ultrasound ﬁndings, incidence of risk factors, and
biochemical data of the two groups were analyzed;
based on these results, which factors predicted the
presence of CAS were determined using stepwise
logistic regression analysis.
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Table 3 Proportion of medication among groups with diffe
Normal (n = 41) 1VD (n = 31)
ACEI 2 (4.9%) 3 (9.7%)
ARB 15 (36.6%) 16 (51.6%)
CCB 8 (19.5%) 15 (48.4%)
Diuretics 6 (14.6%) 3 (9.7%)
Co A vasodilator 4 (10.0%) 14 (45.2%)
Beta-blocker 3 (7.3%) 2 (6.5%)
Aspirin 5 (12.2%) 19 (61.3%)
Statin 9 (22.0%) 11 (35.5%)
SU 2 (4.9%) 5 (16.1%)
ISA 0 (0.0%) 2 (6.5%)
-GI 3 (7.3%) 1 (3.2%)
Data are n (%) with regard to the proportion of subjects on the drug
test. ACEI, angiotensin-converting enzyme inhibitor; ARB, angioten
vasodilator, coronary artery vasodilator; SU, sulfonylurea; ISA, insuHDL-C, high density lipoprotein cholesterol; WBC, white blood
on maximum intima-media thickness; Bmax-IMT, bifurcation
mber.
The background features of four different CAS
everity groups (non-CAS, 1VD, 2VD, and 3VD)
ere compared using Kruskal—Wallis test with
ank score, and one-way ANOVA. Ordinal logis-
ic regression analysis with stepwise was used to
etermine the most relevant factors predicting the
everity of CAS. Receiver operating characteristic
ROC) curve analysis was performed to establish
rent severity of CAS
2VD (n = 24) 3VD (n = 20) p value
2 (8.3%) 1 (5.0%) 0.8496
10 (41.7%) 12 (60.0%) 0.3062
7 (29.2%) 6 (30.0%) 0.0734
1 (4.4%) 6 (30.0%) 0.1111
10 (41.7%) 11 (55.0%) 0.0009
3 (12.5%) 1 (5.0%) 0.8116
12 (50.0%) 16 (80.0%) <0.0001
10 (43.5%) 6 (30.0%) 0.3181
4 (17.4%) 7 (35.0%) 0.0214
5 (20.8%) 2 (10.5%) 0.0105
3 (12.5%) 3 (15.0%) 0.4057
. Analyses were followed by chi-square test, or Fisher’s exact
sin II receptor blocker; CCB, calcium channel blocker; Co A
lin-sensitizing agent; -GL, -glucosidase inhibitor.
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the best threshold PS value of the presence of
CAS.
Results
The initial comparative data between CAS and
non-CAS groups are listed in Table 1. Several
factors were signiﬁcantly different between two
groups. CAS group showed higher age, higher
male ratio, higher incidence of DM and dyslipi-
demia (DL), higher fasting blood sugar (FBS) and
triglyceride (TG), lower high-density lipoprotein
cholesterol (HDL-C), and higher high sensitivity C-
reactive protein (hs-CRP) compared to non-CAS
group. Regarding the incidence of hypertension and
total cholesterol level, there was no difference
between the two groups. All of the IMT data (mean,
Cmax, and Bmax), PS, and PN were signiﬁcantly
higher in CAS group compared to non-CAS group.
The second analysis was performed to exam-
ine the group difference depend on the severity
of CAS (Table 2). Signiﬁcant differences between
four groups were observed for gender, age, the inci-
dence of DM and DL, FBS, TG, HDL-C hs-CRP, and all
of the carotid ultrasound ﬁndings.
To consider the effect of medication of the
present study, medication treated for at least 2
months were considered to be on medication. The
kinds of medications and the proportion of sub-
jects on those medications were listed in Table 3.
The proportion of drug treatment was signiﬁcantly
different in coronary vasodilators, aspirin, sulfony-
lurea, and insulin-sensitizing agent.
Stepwise logistic regression analysis was per-
formed to determine the contributing factors to
the presence of CAS and those results are shown
in Table 4a. High PS and low HDL-C were signif-
Table 4a Stepwise multiple logistic regression anal-
ysis for CA
Variable Unit Odds ratio (95% CI)
PS 1 1.36 (1.18, 1.62)
HDL-C (mg/dl) 10 0.59 (0.38, 0.87)
CAS, stenosis of coronary artery; PS, plaque score; HDL-
C, high density lipoprotein cholesterol; BMI, body mass
index; FBS, fasting blood sugar; SBP, systolic blood pressure;
DBP, diastolic blood pressure; T-chol, total cholesterol; TG,
triglyceride. Stepwise multiple regression analysis for CAS
was performed using variables as quantitative traits together
with age, gender, BMI, smoking status, FBS, SBP, DBP, T-
chol, TG, HDL, andmeasurements in carotid ultrasonography.
As a result, PS and HDL were signiﬁcantly associated with
CAS. The odds ratio of these independent contributors rep-
resented an increase per 1 PS, and 10mg/dl HDL.
Table 4b Stepwise multivariable regression analysis
for four grades of severity of CAS
Variable Unit Odds ratio (95% CI)
PS 1 1.33 (1.20, 1.48)
FBS (mg/dl) 10 1.15 (1.05, 1.26)
HDL-C (mg/dl) 10 0.60 (0.42, 0.83)
CAS, stenosis of coronary artery; PS, plaque score; FBS, fast-
ing blood sugar; HDL-C, high density lipoprotein cholesterol.
We used severity of CAS as the dependent variables, and the
same independent variables in the analysis of Table 4a. Ordi-
nal logistic regression analysis was calculated due to the rank
order of the dependent variable. As a result, PS, FBS, and
HDL were signiﬁcantly associated with severity of CAS. The
odds ratio of these independent contributors represented an
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sincrease per 1 PS, 10mg/dl FBS and 10mg/dl HDL.
cant contributors for the presence of CAS. The
ncrease of PS by 1.0 or the decrease of HDL-C by
0mg/dl correspond to 36% or 41% increased risk
f the presence of CAS, respectively. Another step-
ise logistic regression analysis was performed to
etermine the contributing factor to the severity
f CAS and those data are summarized in Table 4b.
he most contributing factor to the severity of CAS
as high PS and followed by high FBS then low
DL-C. Therefore, high PS was quite signiﬁcant con-
ributing factor to both the presence and severity
f CAS.
Fig. 1 shows data distribution in each severity
rade. Based on these data distribution, the cut-off
oint for PS, which predicts the presence of CAS,
as determined from the receiver operating char-
cteristic curve. Results are shown in Fig. 2. The
ut-off point for predicting the presence of CAS was
.9.
igure 1 Distribution of plaque score value in the dif-
erent severity group of coronary artery stenotic lesions
CAS). Of note are the higher levels of PS value in more
evere CAS groups.
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Figure 2 Receiver operating characteristics (ROC) curve
for PS. Based on the ROC curve in all subjects, an arbi-
trary cut-off value of PS 1.9 was selected. Sensitivity:
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f79.7%; speciﬁcity: 63.4%; accuracy: 73.9%; false positive:
20.3%; false negative: 36.6%. Deviance goodness of ﬁt
statistic; p = 0.8352.
Discussion
The main aim of the present study was to clarify
the relationship between carotid ultrasound ﬁnd-
ings and the presence or severity of CAS in Japanese
patients. Our results provided new ﬁndings in that
the presence of risk factors (high FBS and low HDL-
C) and high PS value in the carotid ultrasonography
have the most substantial impact on determining
the presence and severity of CAS.
Many previous studies have indicated a strong
relationship between ultrasound ﬁndings of the
carotid arteries and CAD [3,7,8,13—18]. The Rot-
terdam study [3] recruited healthy adults aged 55
and more to examined their morbidity and car-
diovascular mortality for the following 7—10 years
and then found that the carotid ultrasound ﬁndings
were the best indicator new onset of myocardial
infarction compared to aortic calciﬁcation in chest
X-ray ﬁlms or ankle-arm index. Kallikazaros et al.
[4] compared the predictive value for the presence
of CAD between sclerotic lesions of the descending
aorta observed by transesophageal echocardiog-
raphy and carotid ultrasound ﬁndings and they
concluded that the latter was a better indica-
tor for the presence of CAD. Ogata et al. [5]
studied the relationship between IMT and left
main trunk calciﬁcation and Sonoda et al. [16]
examined the relationship between coronary ﬂow
and IMT; both reported that high IMT value was
a good indicator of the extent of CAD. More-
over, Kablak-Ziembicka et al. [8] reported that
IMT is signiﬁcantly thicker in a group in which
CAD is present based on coronary angiography
p
s
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ndings and that IMT increases with increased
everity.
These previous reports have clearly shown that
igh IMT observed by carotid ultrasonography has a
trong predictive value for the presence of CAD. Our
esults in the present study also indicated that IMT
alues such as mean-, Bmax- and Cmax-IMT values
ere signiﬁcantly high in CAS group. However, most
f previous reports have used mainly IMT value,
.e. mean-IMT and max-IMT, as the carotid ultra-
ound ﬁndings. A single measurement of carotid
MT is relatively simple and allows easier diagno-
is. Among reports using plaque indicators such as
he PS and PN [5,6,9,10], Sakaguchi et al. [6] stud-
ed the relationship between coronary angiographic
ndings and IMT, PS, or PN, and concluded that IMT
nd PS were equally good indicators of the pres-
nce of CAD. In the present study, stepwise logistic
egression analysis was performed to identify sig-
iﬁcant contributor to the presence of CAS. It turn
ut that PS was better indicator than IMT. A wider
ange observation of the carotid arteries is required
o obtain PS than IMT, therefore, PS value may rep-
esent more precisely the atherosclerotic condition
f the carotid artery than IMT value does, that could
ring the superiority of PS in predicting the pres-
nce of CAS.
Another important point in the present study was
he positive relationship between PS value and the
everity of CAS. The detail relation between both
arameters has not been found as far as our survey
eached. Our present results revealed that high PS
alue predict not only the presence but also the
everity of CAS. The strong correlation between
arotid artery plaque formation and CAS became
pparent. Thus, greater IMT is certainly an impor-
ant indicator for an initial stage of atherosclerotic
esions and a simple way of screening for the pres-
nce of CAS. However, in order to predict the
everity of CAS our results indicated that high PS
alue is more useful than IMT.
Based on the cut-off value determined from the
OC curve, a PS of over 1.9 is considered to indicate
he presence of CAS (Fig. 2). This value appeared to
e lower than expected and several reasons might
e in consideration. First, two cases in non-CAS
roup showed relatively high PS value (Fig. 1). Sec-
nd, not only PS value but also other factor such
s low HDL-C was signiﬁcant predictor for the pres-
nce of CAS. Therefore, in addition to the carotid
ltrasound ﬁndings, the effects of these metabolic
actors appeared to be also important modiﬁer of
redicting the presence of CAS.
Carotid ultrasound ﬁndings like IMT have been
tudied in association to many risk factors of
AD. The association between DM and the scle-
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otic changes in carotid arteries is apparent, and
here are a number of previous reports on this sub-
ect [19—21]. Mitsuhashi et al. [19] reported clear
vidence that the IMT value of the diabetic CAD
atients was signiﬁcantly higher than those of the
iabetic non-CAD patients. Yamasaki et al. [21] also
eported that the predictors of the progression of
arotid IMT in Japanese type 2 diabetic subjects
ere the baseline thickness of IMT and the average
bA1c during the follow-up. The data in the present
tudy also showed association between high FBS and
he presence of CAS (Table 1), even though some
atients were under anti-diabetic medication.
hus, our present data regarding this association
ere in concordance with previous reports.
Additionally, factors showing a signiﬁcant asso-
iation with CAS severity in the present study were
aving a low HDL-C. It is a general consensus that
ow HDL-C level is an important risk factor for both
ew onset and recurrence of CAD. Alagona et al.
22] compared the degree of IMT between non-CAD
ubjects with genetically low HDL-C levels and
hose without and found that IMT was signiﬁcantly
reater in the subjects with low HDL-C. These pre-
iously reported results regarding HDL-C suggest
hat low HDL-C is an independent contributor to
ot only IMT but also CAD. Our ﬁnding of HDL-C
ontribution to the presence and severity of CAS
lso supports the reported role of HDL-C on the
evelopment of CAD.
In the present study, several factors in CAS
roup were signiﬁcantly different those in non-
AS group, but most of them did not remain as
signiﬁcant contributor of the presence or sever-
ty of CAS due to the calibration process of the
tepwise logistic regression analysis. One of them
as high hs-CRP level in CAS group, which could
e important in considering the relation between
therosclerosis and increased inﬂammation. It has
een reported that vascular inﬂammation can be
nduced by the presence of hypertension, dys-
ipidemia, or impaired glucose tolerance. Many
eports have indicated such a relationship between
nﬂammation and atherosclerosis: ICARAS [23]
xamined the relationship between inﬂammation
nd early carotid atherosclerosis and provided a
lose positive correlation between inﬂammation
nd morphological changes of rapidly progressive
arotid atherosclerosis. Our data also showed a sim-
lar signiﬁcant association between PS and hs-CRP
r = 0.33, p < 0.01, data are not shown), thereby this
ould cause that hs-CRP could not remain as a sig-
iﬁcant contributor to the presence of CAS in the
tepwise logistic analysis.
With regard to hypertension, Sonoda et al. [16]
tudied the degree of IMT in three different groups:
p
t
u
a31
atients with CAD, patients with hypertension and
ithout CAD, and without both, and reported sub-
tantially high IMT in the CAD group, followed by
he hypertension group. In addition, Takiuchi et al.
10] studied the relationship between the carotid
ltrasound ﬁndings and hypertensive organopathy
n 350 hypertensive patients and found that themax
MT was the strongest indicator of the hypertensive
rganopathy. These previous results indicate that
ypertension itself affects the carotid ultrasound
nding. In the present study, however, the presence
f hypertension and observed blood pressure levels
id not differ between CAS and non-CAS groups.
his might be because antihypertensive medica-
ions had been administered or the hypotensive
ffect of reduced salt intake under hospitaliza-
ion even in short period. These conditions might
nﬂuence our results because the observed blood
ressure levels were not basal levels. This might
ave affected the present results. However, the
veraged PS value in the hypertensive group (4.3
1.3, 8.0)) was signiﬁcantly higher than that in
on-hypertensive group (1.6 (0.0, 4.0), p < 0.02,
ata not shown), indicating that hypertension itself
ight affect carotid plaque formation, but it was
ot clear for CAS due to modiﬁed blood pressure
evel in our study.
As regards limitations of the present study,
he effect of drug compliance and the thera-
eutic period of medication were not sufﬁciently
n consideration. This might affect the ﬁnal
esults. Our investigation revealed that the uses
f coronary vasodilator, aspirin, sulfonylurea, and
nsulin-sensitizing drug were signiﬁcantly different
etween the different severity groups of CAS. How-
ver, regarding the effect of drug treatment on the
arotid ultrasound ﬁndings, a prospective random-
zed trial is necessary. Since the present study was a
ross-sectional observational study, the signiﬁcance
or the effects of drug treatment was not conclu-
ive.
Another limitation was the subjects: the enrolled
atients in the present study were symptomatic
AD or its suspicion due to some clinical discomfort
uch as chest pain. In fact, those subjects were rel-
tively high risk because majority of the patients
ere complicated with several life style modi-
cation diseases such as hypertension, diabetes
ellitus, hyperlipidemia and obesity. Therefore, it
s not clear whether our results are applicable to
he asymptomatic population. Obviously, a further
tudy is necessary targeting general asymptomatic
opulation and ideally should be prospective study
o address the association between the carotid
ltrasound ﬁndings and not only the presence but
lso the long-term prognosis of CAD.
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Conclusions
Carotid ultrasound parameter especially high PS
value was proved to predict the presence and sever-
ity of CAS. In addition, it has been reconﬁrmed that
the detail assessment of risk factors for CAD was of
great importance.
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